Presentation on theme: "IMI CONFIDENTIAL Journal of Bone and Mineral Research, Vol. 26, No. 11, November 2011, pp 2634–2646, IF= 6.128 You chunyan 2014.05.15 Cell Line IDG-SW3."— Presentation transcript:
IMI CONFIDENTIAL Journal of Bone and Mineral Research, Vol. 26, No. 11, November 2011, pp 2634–2646, IF= 6.128 You chunyan 2014.05.15 Cell Line IDG-SW3 Replicates Osteoblast- to-Late-Osteocyte Differentiation In Vitro and Accelerates Bone Formation In Vivo
www.xianimi.com 2 IMI CONFIDENTIAL Introduction Osteocytes a. No longer considered passive placeholders in bone, osteocytes have emerged in recent years as active, versatile orchestrators of bone remodeling and mineralization. b. Osteocytes are the most abundant bone cells in the body but are the most challenging to study because they are embedded in a lacunocanalicular network within mineralized bone and are relatively difficult to isolate with increasing skeletal age and mineralization. c. Existing cell lines for the study of osteocytes, such as MLO- Y4 and MLO-A5, have limitations including transformation, constitutive expression of the large T antigen, absence of SOST/sclerostin or FGF-23 expression, and/or absence of a mineralized matrix.
www.xianimi.com Introduction 3 IMI CONFIDENTIAL In this report: a. Here we report the establishment and characterization of an Immortomouse/Dmp1-GFP–derived bone cell line (IDG-SW3) capable of overcoming many of the limitations of existing osteocytic cell lines b. Immortomouse-derived cells express a temperature- sensitive mutant of the SV40 large tumor antigen （大 T 抗 原） under the control of the interferon-γ (IFN-γ)– inducible H-2K b promoter (H-2K b -tsA58) at 33 ℃ in the presence of IFN-γ ， inducing continuous proliferation and immortalization.
www.xianimi.com 4 IMI CONFIDENTIAL Materials and Methods Mice Immortomouse （永生化小鼠） Cell lines MLO-A5 cells ： an established model of late osteoblasts with the ability to rapidly synthesize mineralized extracellular matrix. MLO-Y4 cells ： an established model of osteocytes
www.xianimi.com 5 IMI CONFIDENTIAL Materials and Methods Cell culture Cell isolation Real-time PCR Western blot analysis Alkaline phosphatase （ ALP ） assay Cell staining Immunohistochemical staining for collagen type 1 Fluorometric analysis Immunohistochemical staining for sclerostin 3D culture Scanning electron microscopy Mouse calvarial defect model Micro–computed tomographic (CT) analysis
www.xianimi.com 6 IMI CONFIDENTIAL Results 1. Establishment of a cell line representing osteocyte differentiation IDG-SW3 that cells would migrate from the bone chips only if cultured under normal tissue culture conditions at 378C, not immortalizing conditions at 338C in the presence of IFN-g. Moreover, isolated cells would not divide if they were Dmp1-GFP þ.
www.xianimi.com Results 7 IMI CONFIDENTIAL 2. IDG-SW3 cells express SV40 large T antigen under immortalizing conditions but not under osteogenic conditions Fig. 1(A) Total protein was isolated from cells cultured under immortalizing conditions or days 0 -14 under osteogenic conditions for Western blot analysis (left). MLO-A5 cells, which constitutively express the large T antigen driven by the osteocalcin promoter, are a positive control. Relative densitometry of T antigen þ bands normalized toGAPDHis shown (right)
www.xianimi.com 8 IMI CONFIDENTIAL (B) Images of cells under immortalizing conditions 33 ℃ in the presence of IFN-γ) and phase-contrast microscopy. (C) Images of cells after 14 days of osteogenic culture at 37 ℃ in the absence of IFN-γ under fluorescent microscopy. 3. IDG-SW3 cells increase Dmp1-GFP expression under osteogenic conditions over time but not under immortalizing conditions
www.xianimi.com 9 IMI CONFIDENTIAL D. (D) Time course of Dmp1-GFP Þ cells from 0 to 14 days. DAPI- stained cells were imaged under fluorescent and phase-contrast microscopy under osteogenic conditions.
www.xianimi.com 10 IMI CONFIDENTIAL Results (E) Relative percent GFP + cells was determined in representative fields. (F) Relative GFP expression as normalized to total protein. Lysates were fluorometrically quantitated. day 0 is the day after plating and when the cells reached 100% confluence.
www.xianimi.com 11 IMI CONFIDENTIAL (A) ALP expression over 21 days. Cell lysates were assayed for ALP activity at 405 nm, normalized to total protein. (B) Collagen expression in IDG-SW3 cells compared to MLO-A5 cells. 4. IDG-SW3 cells express osteoblastic markers on 2D surfaces in vitro
www.xianimi.com 12 IMI CONFIDENTIAL (C) Mineralization by von Kossa staining. Cells were fixed and stained at 0 to 14 days of differentiation. 5.IDG-SW3 cells increase mineralization and calcium deposition that colocalizes with Dmp1-GFP expression under osteogenic conditions on 2D surfaces in vitro
www.xianimi.com 13 IMI CONFIDENTIAL Results (D) Percent mineralized area increased significantly over time. (E) Alizarin red stain for calcium deposition.
www.xianimi.com 14 IMI CONFIDENTIAL Results (F) Percent calcified area correlates with extracted alizarin red dye. (G) Alizarin red dye quantitation. MLOA5 cells cultured for 9 days demonstrated similar mineralization, whereas MLO-Y4 osteocyte-like cells also did not mineralize. (H) Overlaid images for GFP and alizarin red staining showing GFP + cells closely associated with mineral.
www.xianimi.com 15 IMI CONFIDENTIAL (I) Comparative secondary and backscatter images show nanospherulites and calcospherultes ranging from a few nanometers (arrows, top) to approximately 10mm in diameter (arrows, bottom). (J) Abundant vesicle budding from the cell membrane (arrows, top) and collagen fiber production (arrows, bottom) were observed. Results 6. IDG-SW3 cells produce a dense, extracellular collagen fibril network associated with mineralized spheres on 2D surfaces in vitro
www.xianimi.com 16 IMI CONFIDENTIAL Fig. 3. (A) Correlation of E11 expression with Dmp1-GFP. 7.IDG-SW3 cells express early osteocytic genes on 2D surfaces in vitro
www.xianimi.com 17 IMI CONFIDENTIAL Results (B) E11/gp38 Western blot and quantitation of cell lysates
www.xianimi.com 18 IMI CONFIDENTIAL (C) Time course of Dmp1-GFP+ cells in extended culture. Cells were fixed from days 0 to 35 and stained with DAPI, and representative fields were imaged under fluorescent microscopy.
www.xianimi.com 19 IMI CONFIDENTIAL (D) Relative GFP expression in extended culture as normalized to protein. (E) Relative fold induction ofDmp1mRNA in extended culture.. (F) Relative fold induction of MEPE mRNA and (G) PhexmRNA in IDG- SW3 cells compared with MLO-A5 cells by quantitative RT-PCR.
www.xianimi.com 20 IMI CONFIDENTIAL Results Fig. 4.IDG-SW3 cell expression of late osteocytic markers on 2D surfaces in vitro. (A) Relative fold induction ofSOSTmRNA in IDG- SW3 cells compared with MLO-A5 cells. (C) PTH inhibition ofSOSTexpression.
www.xianimi.com 21 IMI CONFIDENTIAL Results (B) Western blot analysis of sclerostin expression. Total protein isolated at 0 to 35 days demonstrates abundant sclerostin protein.
www.xianimi.com 22 IMI CONFIDENTIAL (D) FGF23 mRNA expression in IDG-SW3 cells. (E) 1,25- Dihydroxyvitamin D3upregulation of FGF-23 expression in IDG-SW3 cells. Results
www.xianimi.com 23 IMI CONFIDENTIAL Fig. 5.Mineralization, infiltration, and expression of osteocytic markers of 3D collagen matrices in vitro. IDG-SW3 cells penetrating 3D matrices. Hematoxylin & eosine staining of decalcified, transverse, paraffin- embedded cells cultured on 3D collagen gel (A) or sponge (B) 7. IDG-SW3 cells infiltrate and mineralize 3D collagen matrices
www.xianimi.com 24 IMI CONFIDENTIAL (C) SEM of IDG-SW3 cells and underlying mineralization on collagen sponge. 7. TRAF4 regulates lung cancer cellular glycolysis that is dependent on Akt activity
www.xianimi.com 25 IMI CONFIDENTIAL (D) EDS analysis of highly mineralized regions detected in backscatter imaging indicates the presence of mineral containing calcium and phosphorus
www.xianimi.com 26 IMI CONFIDENTIAL 8.IDG-SW3 cells express osteocytic genes and display dendritic morphology when cultured on 3D collagen matrices (E) Images of cells on 2D compared with 3D collagen sponge and 3D collagen gel. Cells expressed similar Dmp1-GFP levels.
www.xianimi.com 27 IMI CONFIDENTIAL (F) Images of cell morphology and dendrites in 3D culture.
www.xianimi.com 28 IMI CONFIDENTIAL (G) Sclerostin expression in 3D culture.
www.xianimi.com 9. IDG-SW3 cells accelerate bone healing in vivo 29 IMI CONFIDENTIAL Fig. 6. (A)mCT reconstruction of bone healing within calvarial defects. Shown are 2D coronal slices and 3D superior and inferior views of calvaria captured from reconstructed images at week 7. Increased bone formation is seen in defects containing IDGSW3 cells.
www.xianimi.com 30 IMI CONFIDENTIAL (B)mCT quantitative analysis of bone healing within defects.
www.xianimi.com 31 IMI CONFIDENTIAL (C) Fluorescent images of frozen sections of calvarial defects. Dmp1- GFP+ cells are still detected at the site 7 weeks after implantation, regionally localized with healing bone.
www.xianimi.com 32 IMI CONFIDENTIAL Fig. 7.Schematic diagram summarizing osteoblastic and osteocytic markers in IDG-SW3 cells over time. 10.IDG-SW3 cells have distinct osteocytic gene expression profiles
www.xianimi.com 33 IMI CONFIDENTIAL Discussion IDG-SW3 cells were derived from normal, healthy long bones. They express a full osteogenic differentiation profile from late osteoblast to late osteocyte. Because IDG-SW3 cells are derived from the Immortomouse, these cells possess an IFN-γ-inducible thermolabile large T antigen and are conditionally immortalized. Thus the temperature-sensitive large T antigen can be temporarily turned on for large-scale production of IDG- SW3 cells and later turned off and rapidly degraded for experiments requiring cells with gene expression and function more closely aligned with primary cells. Furthermore, because the cells were derived from the Dmp1-GFP transgenic mouse, IDG-SW3 cells contain a GFP reporter paralleling osteogenic differentiation, enabling live monitoring as the cells transition into osteocytes. Future experiments will explore osteocyte gene regulation and function and how IDG-SW3 cells interact with host cells in vivo.